1 |
Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm.J Am Heart Assoc. 2015 Dec 11;4(12):e002387. doi: 10.1161/JAHA.115.002387.
|
2 |
First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data.Cell Biochem Funct. 2011 Mar;29(2):156-63. doi: 10.1002/cbf.1721. Epub 2011 Feb 2.
|
3 |
Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9.Int J Cardiol. 2013 Oct 9;168(4):3506-13. doi: 10.1016/j.ijcard.2013.04.210. Epub 2013 Jun 3.
|
4 |
A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy.Genet Test Mol Biomarkers. 2012 Aug;16(8):855-8. doi: 10.1089/gtmb.2011.0343. Epub 2012 Apr 23.
|
5 |
Mutation of ARHGAP9 in patients with coronary spastic angina.J Hum Genet. 2010 Jan;55(1):42-9. doi: 10.1038/jhg.2009.120. Epub 2009 Nov 13.
|
6 |
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.J Clin Invest. 2002 Jul;110(2):203-8. doi: 10.1172/JCI15672.
|
7 |
Enhanced transient receptor potential channel-mediated Ca(2+) influx in the cells with phospholipase C-1 overexpression: its possible role in coronary artery spasm.Fundam Clin Pharmacol. 2017 Aug;31(4):383-391. doi: 10.1111/fcp.12269. Epub 2017 Feb 16.
|
|
|
|
|
|
|